HBM Partners finances companies focused on healthcare and entrepreneurial biopharma industries. Moreover, the firm meets the goals of ESG and SDG, supporting companies engaged in R&D. This way, it can select and assists companies with limited negative environmental impact. HBM Partners has an investment fund that helps private and public companies and IPO. The fund is listed on the SIX Swiss Exchange and has an international shareholder base.